PASI Improvement in the First 12 weeks from the Phase 3 VOYAGE 1, VOYAGE 2, ORION and ECLIPSE Guselkumab Clinical Trials. (2023). SKIN The Journal of Cutaneous Medicine, 7(6), s237. https://doi.org/10.25251/skin.7.supp.237